Brief: Rakovina Therapeutics Inc Receives European And Canadian Patents On KT-2000 Series PARP-Inhibitors
08/04/2021 12:17
April 8 (Reuters) - Rakovina Therapeutics Inc RKV.V :
* RAKOVINA THERAPEUTICS INC. RECEIVES EUROPEAN AND CANADIAN
PATENTS ON KT-2000 SERIES PARP-INHIBITORS
Source text for Eikon: ID:nCNWN7xkDa
Further company coverage: RKV.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rakovina Therapeutics
See all newsBrief: Rakovina Therapeutics Announces Three-Month Q2 Ended June 30, 2025 Financial Results And Provides Corporate Update
Brief: Rakovina Therapeutics Announces The Closing Of Oversubscribed Private Placement Of $4.9 Million
Brief: Rakovina Therapeutics Appoints David Kideckel As Chief Financial Officer
Brief: Rakovina Therapeutics Announces 2024 Financial Results
Brief: Rakovina Therapeutics Announces Successful Synthesis Of Novel Small-Molecule Drug Candidates Designed Under AI Platform Collaboration